查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420983

甲状腺疾病治疗市场（疾病：甲状腺功能减退症和甲状腺功能亢进症）-全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Thyroid Gland Disorders Treatment Market (Disorders: Hypothyroidism and Hyperthyroidism) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 173 Pages | 商品交期: 2-10个工作天内

价格

甲状腺疾病治疗市场 - 报告范围

TMR 关于全球甲状腺疾病治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球甲状腺的收入2017-2031 年期间疾病治疗市场，以2023 年为基准年，2031 年为预测年。该报告也提供了2023年至2031年全球甲状腺疾病治疗市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解甲状腺疾病治疗市场。

市场概况
2023年市场价值 22亿美元
2031 年市场价值 33亿美元
CAGR 4.7%

该报告深入探讨了全球甲状腺疾病治疗市场的竞争格局。全球甲状腺疾病治疗市场的主要参与者已经确定，并且每位参与者都根据各种属性进行了分析。公司概述、财务状况、最新发展和 SWOT 是本报告中介绍的全球甲状腺疾病治疗市场参与者的属性。

目录

第 1 章：执行摘要

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 市场区隔
  • 概述
  • 市场动态
  • 2023-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 甲状腺疾病测试类型列表
  • 全球主要国家的疾病盛行率和发生率
  • COVID-19 大流行对该行业的影响

第 6 章：市场分析与预测：依序

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依序，2023-2031
    • 甲状腺功能低下症
      • 左旋甲状腺素
      • 碘塞罗宁
    • 甲状腺功能亢进症
      • 咪唑
      • 丙哌啶
  • 市场吸引力：依无序分类

第 7 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2023-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 8 章：北美市场分析与预测

第 9 章：欧洲市场分析与预测

第 10 章：亚太市场分析与预测

第 11 章：拉丁美洲市场分析与预测

第 12 章：中东和非洲市场分析与预测

第 13 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Merck KGaA
    • Pfizer, Inc.
    • Takeda Pharmaceutical Company Ltd.
    • Allergan
    • Sanofi SA
    • AbbVie Inc.
    • Lannet Company, Inc.
    • Aspen
Product Code: TMRGL3113

Thyroid Gland Disorders Treatment Market - Scope of Report

TMR's report on the global thyroid gland disorders treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thyroid gland disorders treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thyroid gland disorders treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thyroid gland disorders treatment market.

Market Snapshot
Market Value in 2023US$ 2.2 Bn
Market Value in 2031US$ 3.3 Bn
CAGR4.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thyroid gland disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thyroid gland disorders treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thyroid gland disorders treatment market.

The report delves into the competitive landscape of the global thyroid gland disorders treatment market. Key players operating in the global thyroid gland disorders treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thyroid gland disorders treatment market profiled in this report.

Key Questions Answered in Global thyroid gland disorders treatment Market Report:

  • What is the sales/revenue generated by thyroid gland disorders treatment across all regions during the forecast period?
  • What are the opportunities in the global thyroid gland disorders treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Thyroid Gland Disorders Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global thyroid gland disorders treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global thyroid gland disorders treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thyroid gland disorders treatment market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Thyroid Gland Disorders Treatment Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List of Types of Thyroid Gland Disorder Tests
  • 5.3. Disorder Prevalence & Incidence Rate Globally With Key Countries
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Disorder

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disorder, 2023-2031
    • 6.3.1. Hypothyroidism
      • 6.3.1.1. Levothyroxine
      • 6.3.1.2. Liothyronine
    • 6.3.2. Hyperthyroidism
      • 6.3.2.1. Imidazole
      • 6.3.2.2. Propacil
  • 6.4. Market Attractiveness, by Disorder

7. Global Thyroid Gland Disorders Treatment Market Analysis and Forecast, by Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast, by Region, 2023-2031
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness, by Region

8. North America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast, by Disorder, 2023-2031
    • 8.2.1. Hypothyroidism
      • 8.2.1.1. Levothyroxine
      • 8.2.1.2. Liothyronine
    • 8.2.2. Hyperthyroidism
      • 8.2.2.1. Imidazole
      • 8.2.2.2. Propacil
  • 8.3. Market Attractiveness, by Disorder
  • 8.4. Market Value Forecast, by Country, 2023-2031
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Disorder
    • 8.5.2. By Country

9. Europe Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Disorder, 2023-2031
    • 9.2.1. Hypothyroidism
      • 9.2.1.1. Levothyroxine
      • 9.2.1.2. Liothyronine
    • 9.2.2. Hyperthyroidism
      • 9.2.2.1. Imidazole
      • 9.2.2.2. Propacil
  • 9.3. Market Attractiveness, by Disorder
  • 9.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Disorder
    • 9.5.2. By Country/Sub-region

10. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Disorder, 2023-2031
    • 10.2.1. Hypothyroidism
      • 10.2.1.1. Levothyroxine
      • 10.2.1.2. Liothyronine
    • 10.2.2. Hyperthyroidism
      • 10.2.2.1. Imidazole
      • 10.2.2.2. Propacil
  • 10.3. Market Attractiveness, by Disorder
  • 10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Disorder
    • 10.5.2. By Country/Sub-region

11. Latin America Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disorder, 2023-2031
    • 11.2.1. Hypothyroidism
      • 11.2.1.1. Levothyroxine
      • 11.2.1.2. Liothyronine
    • 11.2.2. Hyperthyroidism
      • 11.2.2.1. Imidazole
      • 11.2.2.2. Propacil
  • 11.3. Market Attractiveness, by Disorder
  • 11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Disorder
    • 11.5.2. By Country/Sub-region

12. Middle East & Africa Thyroid Gland Disorders Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disorder, 2023-2031
    • 12.2.1. Hypothyroidism
      • 12.2.1.1. Levothyroxine
      • 12.2.1.2. Liothyronine
    • 12.2.2. Hyperthyroidism
      • 12.2.2.1. Imidazole
      • 12.2.2.2. Propacil
  • 12.3. Market Attractiveness, by Disorder
  • 12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Disorder
    • 12.5.2. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 13.2. Market Share Analysis, by Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Merck KGaA
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Disorder Portfolio
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Pfizer, Inc.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Disorder Portfolio
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. SWOT Analysis
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Takeda Pharmaceutical Company Ltd.
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Disorder Portfolio
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. SWOT Analysis
      • 13.3.3.5. Strategic Overview
    • 13.3.4. Allergan
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Disorder Portfolio
      • 13.3.4.3. Financial Overview
      • 13.3.4.4. SWOT Analysis
      • 13.3.4.5. Strategic Overview
    • 13.3.5. Sanofi S.A.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Disorder Portfolio
      • 13.3.5.3. Financial Overview
      • 13.3.5.4. SWOT Analysis
      • 13.3.5.5. Strategic Overview
    • 13.3.6. AbbVie Inc.
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Disorder Portfolio
      • 13.3.6.3. Financial Overview
      • 13.3.6.4. SWOT Analysis
      • 13.3.6.5. Strategic Overview
    • 13.3.7. Lannet Company, Inc.
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Disorder Portfolio
      • 13.3.7.3. Financial Overview
      • 13.3.7.4. SWOT Analysis
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Aspen
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Disorder Portfolio
      • 13.3.8.3. Financial Overview
      • 13.3.8.4. SWOT Analysis
      • 13.3.8.5. Strategic Overview

List of Tables

  • Table 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 2: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 3: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 4: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 5: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 6: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 7: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 8: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 9: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031
  • Table 11: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2032-2031
  • Table 12: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2023-2031

List of Figures

  • Figure 1: Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 2: Global Thyroid Gland Disorders Treatment Market Value Share, by Disorder, 2022
  • Figure 3: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 4: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 5: Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 6: Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 7: North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 8: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 9: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 10: North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 11: North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 12: Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 13: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 14: Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 15: Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 16: Europe America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 17: Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 18: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 19: Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 20: Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 21: Asia Pacific America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 22: Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 23: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2022 and 2031
  • Figure 26: Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 27: Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 28: Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 29: Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30: Middle East & Africa America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2023-2031
  • Figure 31: Middle East & Africa America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2023-2031
  • Figure 32: Global Thyroid Gland Disorders Treatment Market Share Analysis, by Company (2022)